ArticleOncotarget2016

A novel HSP90 inhibitor with reduced hepatotoxicity synergizes with radiotherapy to induce apoptosis, abrogate clonogenic survival, and improve tumor control in models of colorectal cancer.

Linda Kinzel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.